COLLEGE, Pa.--(BUSINESS WIRE--NanoHorizons, Inc., an
emerging leader in nano-scale material and device technologies,
today announced a research collaboration with Arrow
International, Inc. (NASDAQ:ARRO), a leading supplier
of clinically advanced disposable catheters based in
Reading, PA, to develop opportunities to apply state
of the art nano-technology to numerous emerging cost
and performance issues in biomedical technology. It
brings together the latest in new materials and device
technology, and the practical experience and commercial
success needed to focus such development.
are particularly pleased to partner with another forward-thinking
Pennsylvania corporation," says Dr. Stephen Fonash,
founder and Chairman of NanoHorizons. "Arrow's
experience in the biomedical industry is invaluable
to our efforts to bring nanotechnology to market in
unique products, critical to the continuing effort
to improve medical care," adds Robert Burlinson,
President and CEO of NanoHorizons, Inc.
About NanoHorizons, Inc.
NanoHorizons, Inc. was founded in 2002 with a business
focus on nanotechnology applications in the drug discovery,
microelectronics and health care industries. The company
has licensed a comprehensive portfolio of nanotechnology
Intellectual Property from the Pennsylvania State
The initial product offering, QuickMass(TM) matrix
free laser desorption plates, addresses the need for
more cost effective pharmaceutical research and increased
drug discovery capacity. Additional commercial initiatives
are being pursued to meet needs for fast, high-sensitivity
respiration monitors as well as humidity and gas sensors.
Further, a manufacturing process used to place high
performance logic, sensors, displays, MEMS and optoelectronics
on inexpensive or mechanically flexible substrates
offers licensing opportunities.
For more information, visit
About Arrow International, Inc.
Arrow International, Inc. develops, manufactures and
markets a broad range of clinically advanced, disposable
catheters and related products for critical and cardiac
care. The Company's products are used primarily by
anesthesiologists, critical care specialists, surgeons,
emergency and trauma physicians, cardiologists, interventional
radiologists, electrophysiologists, and other health
care providers. The Company's common stock trades
on The Nasdaq Stock Market(R) under the symbol ARRO.
For more information, visit www.arrowintl.com